$10.9 Billion is the total value of ArrowMark Colorado Holdings LLC's 340 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -150 | -100.0% | 0.00% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -3,135 | -100.0% | -0.00% | – |
| CCEP | Exit | COCA COLA EUROPEAN PARTNERS | $0 | – | -7,500 | -100.0% | -0.00% | – |
| DIS | Exit | DISNEY WALT CO | $0 | – | -4,724 | -100.0% | -0.01% | – |
| SWCH | Exit | SWITCH INCcall | $0 | – | -50,000 | -100.0% | -0.01% | – |
| ISD | Exit | PRUDENTIAL SHT DURATION HG Y | $0 | – | -97,129 | -100.0% | -0.01% | – |
| DYN | Exit | DYNEGY INC NEW DEL | $0 | – | -142,100 | -100.0% | -0.02% | – |
| HPE | Exit | HEWLETT PACKARD ENTERPRISE C | $0 | – | -115,000 | -100.0% | -0.02% | – |
| UNH | Exit | UNITEDHEALTH GROUP INCput | $0 | – | -10,000 | -100.0% | -0.02% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -935,987 | -100.0% | -0.04% | – |
| COST | Exit | COSTCO WHSL CORP NEWcall | $0 | – | -21,000 | -100.0% | -0.04% | – |
| SBUX | Exit | STARBUCKS CORPcall | $0 | – | -100,000 | -100.0% | -0.06% | – |
| WMT | Exit | WALMART INCput | $0 | – | -100,000 | -100.0% | -0.09% | – |
| USB | Exit | US BANCORP DEL | $0 | – | -183,100 | -100.0% | -0.09% | – |
| TSLA | Exit | TESLA INCcall | $0 | – | -100,000 | -100.0% | -0.27% | – |
| AXON | Exit | AXON ENTERPRISE INC | $0 | – | -746,453 | -100.0% | -0.29% | – |
| ABMD | Exit | ABIOMED INC | $0 | – | -125,007 | -100.0% | -0.36% | – |
| NEWR | Exit | NEW RELIC INC | $0 | – | -588,442 | -100.0% | -0.44% | – |
| MMS | Exit | MAXIMUS INC | $0 | – | -730,038 | -100.0% | -0.49% | – |
| LULU | Exit | LULULEMON ATHLETICA INC | $0 | – | -987,656 | -100.0% | -0.88% | – |
| CALD | Exit | CALLIDUS SOFTWARE INC | $0 | – | -2,810,531 | -100.0% | -1.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COOPER COS INC | 42 | Q3 2023 | 1.7% |
| SPDR GOLD TRUST | 42 | Q3 2023 | 6.4% |
| CITIGROUP INC | 42 | Q3 2023 | 10.1% |
| CHENIERE ENERGY INC | 42 | Q3 2023 | 3.0% |
| JPMORGAN CHASE & CO | 42 | Q3 2023 | 5.7% |
| EOG RES INC | 42 | Q3 2023 | 1.8% |
| MICROSOFT CORP | 42 | Q3 2023 | 0.7% |
| APPLE INC | 42 | Q3 2023 | 1.0% |
| WEYERHAEUSER CO MTN BE | 42 | Q3 2023 | 1.5% |
| WALKER & DUNLOP INC | 42 | Q3 2023 | 0.7% |
View ArrowMark Colorado Holdings LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| C4 Therapeutics, Inc. | June 12, 2023 | 1,493,450 | 3.0% |
| Frontdoor, Inc. | May 10, 2023 | 3,463,478 | 4.2% |
| CHANNELADVISOR CORPSold out | February 15, 2023 | 0 | 0.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 15, 2023 | 3,560,848 | 3.0% |
| HUDSON TECHNOLOGIES INC /NY | February 15, 2023 | 2,091,927 | 4.6% |
| KnowBe4, Inc.Sold out | February 15, 2023 | 0 | 0.0% |
| MERIT MEDICAL SYSTEMS INC | February 15, 2023 | 2,517,226 | 4.4% |
| NexImmune, Inc. | February 15, 2023 | 10,924 | 0.0% |
| SKECHERS USA INC | February 15, 2023 | 4,332,217 | 3.2% |
| Talis Biomedical Corp | February 15, 2023 | 1,159,016 | 4.3% |
View ArrowMark Colorado Holdings LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ArrowMark Colorado Holdings LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.